Yu Hsuan Aria Shih
About Yu Hsuan Aria Shih
Yu Hsuan Aria Shih is the Associate Director of Global Health Economics & Outcomes Research at Bristol Myers Squibb in Madison, New Jersey, with a background in health economics and epidemiology.
Company
Yu Hsuan Aria Shih is currently associated with Bristol Myers Squibb, where she serves as Associate Director, Global Health Economics & Outcomes Research. Located in Madison, New Jersey, Bristol Myers Squibb is a multinational pharmaceutical company known for its significant contributions to healthcare and medical research.
Title
Currently, Yu Hsuan Aria Shih holds the position of Associate Director, Global Health Economics & Outcomes Research at Bristol Myers Squibb. Her role involves overseeing research activities that assess the economic and health outcomes of pharmaceutical products, contributing to strategic decision-making within the company.
Education and Expertise
Yu Hsuan Aria Shih possesses a robust educational background in epidemiology and public health. She earned her Doctor of Philosophy (PhD) in Epidemiology from the University of Illinois Chicago, where she studied from 2015 to 2020. Prior to that, she obtained a Master of Science (MS) in Epidemiology and a Bachelor of Science (BS) in Public Health from National Taiwan University. Her academic accomplishments are further demonstrated through her multiple peer-reviewed publications and presentations at international conferences like ISPOR.
Professional Background
Yu Hsuan Aria Shih's professional journey includes significant roles in various renowned organizations. Before joining Bristol Myers Squibb, she worked at Novartis as Manager, Health Economics & Outcomes Research (2021-2023) and contributed by developing a cost-effectiveness model for a new cardiovascular drug. She also held the position of Postdoctoral Research Fellow at Harvard T.H. Chan School of Public Health (2020-2021), participating in a major collaborative research project. Additionally, she has experience working at Amgen, AbbVie, and University of Illinois at Chicago in various research and teaching capacities.
Research Contributions
Yu Hsuan Aria Shih has made substantial contributions to the field of health economics and outcomes research. She has published multiple peer-reviewed articles and presented her findings at international platforms such as ISPOR. At Bristol Myers Squibb, she actively mentors junior researchers and interns. During her tenure at Novartis, she led the development of a cost-effectiveness model for a new cardiovascular drug. She has also been involved in significant projects such as systematic reviews, meta-analyses on economic burdens of chronic diseases, and the development of health policy recommendations in Taiwan.